Viral Genetics, Inc. (VRAL.PK) Receives Patent for Cancer Treatment Therapies
Viral Genetics, Inc., a company that develops drug compounds to treat cancer, Lyme Disease, and HIV, has received a patent for cancer treatment therapies. This patent protects cancer drugs that have used mice as clinical research subjects. Issued on March 31, 2009, the U.S. Patent Number is: 7,510,710. M. Karen Newell, PhD., tenured professor at the University of Colorado, stated, "This patent represents the first method for treating drug resistant cancer using metabolic disruption, an approach targeting the distinct cancer-specific metabolic activities that can distinguish cancer cells in general, and many drug resistant cancer types, in specific, from normal cells…